Cargando…

Increased Serum Uric Acid Level Is a Risk Factor for Left Ventricular Hypertrophy but Not Independent of eGFR in Patients with Type 2 Diabetic Kidney Disease

BACKGROUND: Although the relation between serum uric acid (SUA) and left ventricular hypertrophy (LVH) has been studied for decades, however, their association remains debatable. METHODS: This is a retrospective study in which a total of 435 hospitalized Chinese patients with type 2 DKD were enrolle...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Chuchu, Cheng, Dongsheng, Sheng, Xiaohua, Jian, Guihua, Fan, Ying, Chen, Yuqiang, Li, Junhui, Bao, Hongda, Wang, Niansong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496120/
https://www.ncbi.nlm.nih.gov/pubmed/28713836
http://dx.doi.org/10.1155/2017/5016093
_version_ 1783247905795080192
author Zeng, Chuchu
Cheng, Dongsheng
Sheng, Xiaohua
Jian, Guihua
Fan, Ying
Chen, Yuqiang
Li, Junhui
Bao, Hongda
Wang, Niansong
author_facet Zeng, Chuchu
Cheng, Dongsheng
Sheng, Xiaohua
Jian, Guihua
Fan, Ying
Chen, Yuqiang
Li, Junhui
Bao, Hongda
Wang, Niansong
author_sort Zeng, Chuchu
collection PubMed
description BACKGROUND: Although the relation between serum uric acid (SUA) and left ventricular hypertrophy (LVH) has been studied for decades, however, their association remains debatable. METHODS: This is a retrospective study in which a total of 435 hospitalized Chinese patients with type 2 DKD were enrolled. The subjects were stratified into quartiles according to SUA level. LVH was assessed by two-dimensional guided M-mode echocardiography. RESULTS: There was a significant increase in the prevalence of LVH in patients with type 2 DKD across SUA quartiles (28.9, 26.5, 36.1, and 49.5%; p < 0.001). The Spearman analysis indicated that SUA was positively correlated to LVMI and negatively correlated to eGFR. The logistic regression analysis revealed that the odd ratio for LVH in the highest SUA quartile was 2.439 (95% CI 1.265–4.699; p = 0.008; model 1) or 2.576 (95% CI 1.150–5.768; p = 0.021; model 2) compared with that in the lowest SUA quartile. However, there was no significant increased risk of LVH in the subjects with the highest SUA quartile after adjusting the eGFR (OR = 1.750; 95% CI 0.685–4.470; p = 0.242; model 3). CONCLUSIONS: In selected population, such as type 2 DKD, the elevated SUA level is positively linked with the increased risk of LVH, but this relationship is not independent of eGFR.
format Online
Article
Text
id pubmed-5496120
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-54961202017-07-16 Increased Serum Uric Acid Level Is a Risk Factor for Left Ventricular Hypertrophy but Not Independent of eGFR in Patients with Type 2 Diabetic Kidney Disease Zeng, Chuchu Cheng, Dongsheng Sheng, Xiaohua Jian, Guihua Fan, Ying Chen, Yuqiang Li, Junhui Bao, Hongda Wang, Niansong J Diabetes Res Research Article BACKGROUND: Although the relation between serum uric acid (SUA) and left ventricular hypertrophy (LVH) has been studied for decades, however, their association remains debatable. METHODS: This is a retrospective study in which a total of 435 hospitalized Chinese patients with type 2 DKD were enrolled. The subjects were stratified into quartiles according to SUA level. LVH was assessed by two-dimensional guided M-mode echocardiography. RESULTS: There was a significant increase in the prevalence of LVH in patients with type 2 DKD across SUA quartiles (28.9, 26.5, 36.1, and 49.5%; p < 0.001). The Spearman analysis indicated that SUA was positively correlated to LVMI and negatively correlated to eGFR. The logistic regression analysis revealed that the odd ratio for LVH in the highest SUA quartile was 2.439 (95% CI 1.265–4.699; p = 0.008; model 1) or 2.576 (95% CI 1.150–5.768; p = 0.021; model 2) compared with that in the lowest SUA quartile. However, there was no significant increased risk of LVH in the subjects with the highest SUA quartile after adjusting the eGFR (OR = 1.750; 95% CI 0.685–4.470; p = 0.242; model 3). CONCLUSIONS: In selected population, such as type 2 DKD, the elevated SUA level is positively linked with the increased risk of LVH, but this relationship is not independent of eGFR. Hindawi 2017 2017-06-20 /pmc/articles/PMC5496120/ /pubmed/28713836 http://dx.doi.org/10.1155/2017/5016093 Text en Copyright © 2017 Chuchu Zeng et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Zeng, Chuchu
Cheng, Dongsheng
Sheng, Xiaohua
Jian, Guihua
Fan, Ying
Chen, Yuqiang
Li, Junhui
Bao, Hongda
Wang, Niansong
Increased Serum Uric Acid Level Is a Risk Factor for Left Ventricular Hypertrophy but Not Independent of eGFR in Patients with Type 2 Diabetic Kidney Disease
title Increased Serum Uric Acid Level Is a Risk Factor for Left Ventricular Hypertrophy but Not Independent of eGFR in Patients with Type 2 Diabetic Kidney Disease
title_full Increased Serum Uric Acid Level Is a Risk Factor for Left Ventricular Hypertrophy but Not Independent of eGFR in Patients with Type 2 Diabetic Kidney Disease
title_fullStr Increased Serum Uric Acid Level Is a Risk Factor for Left Ventricular Hypertrophy but Not Independent of eGFR in Patients with Type 2 Diabetic Kidney Disease
title_full_unstemmed Increased Serum Uric Acid Level Is a Risk Factor for Left Ventricular Hypertrophy but Not Independent of eGFR in Patients with Type 2 Diabetic Kidney Disease
title_short Increased Serum Uric Acid Level Is a Risk Factor for Left Ventricular Hypertrophy but Not Independent of eGFR in Patients with Type 2 Diabetic Kidney Disease
title_sort increased serum uric acid level is a risk factor for left ventricular hypertrophy but not independent of egfr in patients with type 2 diabetic kidney disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496120/
https://www.ncbi.nlm.nih.gov/pubmed/28713836
http://dx.doi.org/10.1155/2017/5016093
work_keys_str_mv AT zengchuchu increasedserumuricacidlevelisariskfactorforleftventricularhypertrophybutnotindependentofegfrinpatientswithtype2diabetickidneydisease
AT chengdongsheng increasedserumuricacidlevelisariskfactorforleftventricularhypertrophybutnotindependentofegfrinpatientswithtype2diabetickidneydisease
AT shengxiaohua increasedserumuricacidlevelisariskfactorforleftventricularhypertrophybutnotindependentofegfrinpatientswithtype2diabetickidneydisease
AT jianguihua increasedserumuricacidlevelisariskfactorforleftventricularhypertrophybutnotindependentofegfrinpatientswithtype2diabetickidneydisease
AT fanying increasedserumuricacidlevelisariskfactorforleftventricularhypertrophybutnotindependentofegfrinpatientswithtype2diabetickidneydisease
AT chenyuqiang increasedserumuricacidlevelisariskfactorforleftventricularhypertrophybutnotindependentofegfrinpatientswithtype2diabetickidneydisease
AT lijunhui increasedserumuricacidlevelisariskfactorforleftventricularhypertrophybutnotindependentofegfrinpatientswithtype2diabetickidneydisease
AT baohongda increasedserumuricacidlevelisariskfactorforleftventricularhypertrophybutnotindependentofegfrinpatientswithtype2diabetickidneydisease
AT wangniansong increasedserumuricacidlevelisariskfactorforleftventricularhypertrophybutnotindependentofegfrinpatientswithtype2diabetickidneydisease